Although there was an increased rate of virologic failure in patients with HCV GT2b infection in study GIFT‐II, SVR12 rates were similar in GT2b‐infected patients with or without an NS3 or NS5A polymorphism at baseline (Table 3). Here, KRAS is linked to infection.